Ribston Pharmaceuticals Private Limited
About Ribston Pharmaceuticals Private Limited
Data last updated:
Ribston Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 02 December 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51101DL2013PTC261444. Its GSTIN is 07AAGCR7315A1ZP (Delhi).
The company has an authorised share capital of ₹3 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Chandra Nayal and Ramendra Singh Nayal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D – 6/4 Street No. 4 Ground Floor Sangam Vihar, New Delhi, Delhi, India – 110080.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.93 Lakh, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹32,519 (net margin 3.3%) and EBITDA of ₹45,437 (EBITDA margin 4.6%). Revenue has declined at a compounded annual rate (CAGR) of 5% over three years and 2% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ribston Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressD – 6/4 Street No. 4 Ground Floor Sangam Vihar, New Delhi, Delhi, India – 110080
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Ribston Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ribston Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Ribston Pharmaceuticals Private Limited, buy the company report.
Financials of Ribston Pharmaceuticals Private Limited
FY 2025 filings availableRibston Pharmaceuticals Private Limited reported revenue of ₹9.93 Lakh (up 11% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 11% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 2%. EBITDA rose 68% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹45,437 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹32,519 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.6% | ||||
| Net Profit Margin | 3.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ribston Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ribston Pharmaceuticals Private Limited
Ribston Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandra Nayal | Director | 15 Jul 2021 | 5 Years 3 Months | Current |
| Ramendra Singh Nayal | Director | 02 Dec 2013 | 12 Years 10 Months | Current |
Auditor
Ribston Pharmaceuticals Private Limited is audited by N.K.VAISH & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N.K.VAISH & CO. | FY 2017 | 509375 |
Shareholding
The shareholding of Ribston Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Ribston Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ribston Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ribston Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ribston Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAGCR7315A1ZP | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ribston Pharmaceuticals Private Limited, buy the company report.
Recent activity
Ribston Pharmaceuticals Private Limited has 4 board changes on record since 2013: 2 appointments and 2 cessations. The latest: Amit Thakur ceased to be Director on 15 Jul 2021.
Frequently asked questions
Ribston Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in wholesale, within the trading industry. It was incorporated on 02 December 2013 (13+ years old) and is registered under CIN U51101DL2013PTC261444.
Ribston Pharmaceuticals has 2 current directors:
- Chandra Nayal - Director
- Ramendra Singh Nayal - Director
The latest financial statements of Ribston Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Ribston Pharmaceuticals is 07AAGCR7315A1ZP, registered in Delhi.
The CIN (Corporate Identification Number) of Ribston Pharmaceuticals is U51101DL2013PTC261444. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ribston Pharmaceuticals was incorporated on 02 December 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.
Amit Thakur ceased to be Director on 15 Jul 2021. Chandra Nayal was appointed as Director on 15 Jul 2021. Dheeraj Nayal ceased to be Director on 30 Jun 2018. Ribston Pharmaceuticals has 4 board changes on record in total.
The registered office of Ribston Pharmaceuticals is at D – 64 Street No. 4 Ground Floor Sangam Vihar, New Delhi, Delhi, India – 110080.
Ribston Pharmaceuticals operates in the trading industry, in the wholesale segment.
The compliance status of Ribston Pharmaceuticals is compliant as of 06 September 2026. The company is actively filing with the Registrar of Companies.